Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222

Objective: To determine whether severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody levels after the first dose of vaccine can predict the final antibody response, and whether this is dependent on the vaccine type. Methods: Sixty-nine recipients of BNT162b2 (Pfizer/BioNTech) and 55...

Descripción completa

Detalles Bibliográficos
Autores principales: Perkmann, Thomas, Perkmann-Nagele, Nicole, Mucher, Patrick, Radakovics, Astrid, Repl, Manuela, Koller, Thomas, Jordakieva, Galateja, Wagner, Oswald F., Binder, Christoph J., Haslacher, Helmuth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317449/
https://www.ncbi.nlm.nih.gov/pubmed/34332084
http://dx.doi.org/10.1016/j.ijid.2021.07.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317449/
https://www.ncbi.nlm.nih.gov/pubmed/34332084
http://dx.doi.org/10.1016/j.ijid.2021.07.063

Ejemplares similares